drugset / Trial / NCT03374280
Pemetrexed/Cisplatin Intercalating Gefitinib Treating EGFR Wild NSCLC
RandomizedParallel-groupOpen-labelTreatment
Summary
To investigate the curative effect between Pemetrexed/Cisplatin and Pemetrexed/Cisplatin intercalating Gefitinib Treating EGFR Wild NSCLC
Timeline
- Start
- 2016-12-01
- Primary completion
- 2019-12-30
- Completion
- 2021-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gefitinib | Small molecule | 250 mg | — |
| Background | Cisplatin | Other / unclassified | 30 mg/m2 | — |
| Background | Pemetrexed | Small molecule | 500 mg/m2 | — |